ARTICLE | Clinical News
BiovaxID dasiprotimut-T regulatory update
January 20, 2014 8:00 AM UTC
Biovest said EMA accepted for review an MAA for BiovaxID to treat follicular non-Hodgkin's lymphoma (NHL). BiovaxID is an autologous vaccine containing tumor-specific idiotype proteins from an individ...